Molyneux E, Walsh A, Phiri A, Molyneux M
Paediatric Department, College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.
Trop Med Int Health. 1998 Aug;3(8):610-8. doi: 10.1046/j.1365-3156.1998.00278.x.
To design appropriate interventions, we collected clinical and demographic data prospectively on all children aged one day to 14 years admitted with a diagnosis of bacterial meningitis (BM) from April 1st 1996 to March 31st 1997 to the Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi. During the study period 267 children (2.7% of all paediatric admissions) were found to have BM; 83% were under 5 years of age, 61% under one year and 23% under one month. The most common causative organisms in the post neonatal period (n=206) were Streptococcus pneumoniae (27%), Haemophilus influenzae type b (Hib) 21%, and Salmonella typhimurium (6%). In the neonatal group (< 1 month, n=61) the most common causes were Streptococcus agalactiae (23%), S. typhimurium (15%), S. pneumoniae (11.5%) and other Gram negative rods (11.5%). Nineteen of 21 salmonella infections were in children under one year of age and all S. agalactiae were in infants under three months. There was delay on presentation: the average length of fever was 4.6 days, 39.5% had convulsed prior to arrival and 57% had an altered level of consciousness. An initial diagnosis of malaria had probably contributed to the delay in 22.5% (42 of 186 tested). 48% were < 80% weight for age, with 18% < 60%) weight for age. The overall mortality was 40%. The outcome was worst in salmonella infections, particularly neonatal salmonella BM with a case fatality rate (CFR) of 89% (8 of 9 cases). Coma on presentation worsened prognosis (mortality 64% if Blantyre Coma Score < 3, 26% if > 3). 15% of survivors had sequelae on discharge. 20% of Hib isolates were resistant to chloramphenicol, but all salmonellae were sensitive. 5% of S. pneumoniae were resistant to penicillin and 8% to chloramphenicol. Earlier access to adequate health care and awareness of BM in a malaria-endemic area would reduce mortality and morbidity. Vaccination against Hib infection would have reduced death by 18 (17%) and prevented sequelae in 7 cases.
为设计恰当的干预措施,我们前瞻性收集了1996年4月1日至1997年3月31日期间,在马拉维布兰太尔伊丽莎白女王中央医院(QECH)收治的所有年龄在1天至14岁、诊断为细菌性脑膜炎(BM)的儿童的临床和人口统计学数据。在研究期间,发现267名儿童(占所有儿科住院病例的2.7%)患有BM;83%年龄在5岁以下,61%年龄在1岁以下,23%年龄在1个月以下。新生儿期后(n = 206)最常见的病原体是肺炎链球菌(27%)、b型流感嗜血杆菌(Hib,21%)和鼠伤寒沙门氏菌(6%)。在新生儿组(<1个月,n = 61)中,最常见的病因是无乳链球菌(23%)、鼠伤寒沙门氏菌(15%)、肺炎链球菌(11.5%)和其他革兰氏阴性杆菌(11.5%)。21例沙门氏菌感染中有19例发生在1岁以下儿童,所有无乳链球菌感染均发生在3个月以下婴儿。就诊存在延迟:平均发热时长为4.6天,39.5%在入院前发生惊厥,57%意识水平改变。初步诊断为疟疾可能导致了22.5%(186例检测者中的42例)的延迟。48%年龄别体重<80%,18%年龄别体重<60%。总体死亡率为40%。沙门氏菌感染的预后最差,尤其是新生儿鼠伤寒沙门氏菌BM,病死率(CFR)为89%(9例中的8例)。就诊时昏迷会使预后恶化(如果布兰太尔昏迷评分<3,死亡率为64%;如果>3,死亡率为)26%)。15%的幸存者出院时有后遗症。20%的Hib分离株对氯霉素耐药,但所有沙门氏菌均敏感。5%的肺炎链球菌对青霉素耐药,8%对氯霉素耐药。在疟疾流行地区更早获得充分的医疗保健以及提高对BM的认识将降低死亡率和发病率。接种Hib疫苗可减少18例死亡(17%),并预防7例后遗症。